Mesenchymal Stem/Stromal Cells for Therapeutic Angiogenesis

Area of Science:

• Regenerative Medicine
• Vascular Biology
• Cell Therapy

Background:

• Mesenchymal stem/stromal cells (MSCs) exhibit therapeutic properties for vascular repair.
• Advances in MSC technology enable their application in treating vascular diseases.
• Conditions like peripheral artery disease significantly impact patient morbidity.

Purpose of the Study:

• To review the current applications of MSCs in therapeutic angiogenesis.
• To discuss MSC-based treatments for vascular regeneration and chronic wounds.
• To explore MSCs as a monotherapy or adjunct for peripheral artery disease.

Main Methods:

• Review of current literature on MSCs in vascular regeneration.
• Analysis of MSC isolation, expansion, and enhancement strategies.
• Evaluation of MSCs in treating chronic arterial occlusive disease, diabetic ulcers, and chronic wounds.

Main Results:

• MSCs facilitate vascular regeneration and promote therapeutic angiogenesis.
• Cell therapy with MSCs offers potential for wound healing and improving amputation-free survival.
• MSCs show promise in both monotherapy and combination treatments for vascular diseases.

Conclusions:

• MSCs are a viable option for therapeutic angiogenesis in vascular research and medicine.
• Further research into MSC applications can improve outcomes for patients with peripheral artery diseases.
• MSC-based therapies hold potential for managing chronic wounds and improving limb salvage.